Family fears Medicaid cuts would mean rationing treatments for child
Kennedy Beaver has been going to therapy sessions at least twice a week after she was diagnosed with Noonan syndrome, a genetic condition that stunts development.
The 6-year-old from North Carolina is among 600,000 people in the state who could lose access to healthcare as Congress is poised to approve major cuts to Medicaid funding proposed in President Trump's so-called "big, beautiful bill," according to according to the state's Medicaid office.
"For her, that's short stature, poor growth, low muscle tone," her mother, Marilyn, described Kennedy's condition in an interview with CBS News. "So with that, we became eligible for something called the CAP/C waiver through Medicaid."
North Carolina's Community Alternatives Program for Children pays for most of the treatments and medications for patients younger than 20 who have significant medical needs. If the Beavers didn't have CAP/C, the family says they would be paying over $4,000 a month for treatments and medications — even with private health insurance coverage.
"This is our medication that, without the Medicaid coverage, would be $3,200 a month, because our primary insurance has denied us," Marilyn said. The family says they also fear that if the proposal on Capitol Hill becomes law, they may have to go back to rationing Kennedy's treatment.
North Carolina Medicaid Deputy Secretary Jay Ludlam says the cut that's being proposed at the federal level will "at some point affect the entire program."
The state's Medicaid program oversees more than 3 million people who currently receive the healthcare benefits. State officials say if federal funding falls short, the CAP/C program could be on the chopping block.
"When you take $700 billion out of Medicaid nationally ... there's no way to really do that without people losing coverage, without having to change the benefits and the coverage that people get," Ludlam said.
When asked what she would tell lawmakers in Congress if she had the opportunity to speak with them, Marilyn said they should make changes without cutting services.
"It's fixing the healthcare system so that everyone in the country can get a level of care that meets their needs," she said.
Saving money vs. saving lives
The true cost of the Senate spending bill
New Tennessee laws make it illegal to shelter undocumented immigrants
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
Q'Apel Medical Appoints Stewart Strong as President and Chief Executive Officer
Innovation-focused leader with a proven track record of driving outsized growth and profitability to lead the company's next chapter FREMONT, Calif., July 1, 2025 /PRNewswire/ -- Q'Apel Medical (Q'Apel), a private medical device company focused on revolutionizing neurovascular interventions, today announced the appointment of veteran medtech executive, Stewart Strong, as President and Chief Executive Officer. In this role, Strong will lead Q'Apel's team as it looks to expand its market presence, deliver clinical value for physicians and patients, and advance the company's pipeline of innovation. "Stew is the right person at the right time to lead Q'Apel through our next phase of growth," remarked R. King Nelson, Q'Apel's Chairman of the Board. "He brings a passion for building and leading high-performing global teams and for developing commercial strategies to drive sustainable growth, which will serve him well as Q'Apel looks to accelerate our commercial performance in the U.S. and ramp up our global presence." With over 25 years of leadership experience in the medical device sector, Mr. Strong brings a wealth of experience in creating high-performing global teams, both in large, publicly traded enterprises and privately backed organizations. He comes to Q'Apel from Haemonetics, where he served as Global President of the Hospital Business Unit. In this role, Strong established a world-class global commercial organization, launched innovative technologies, and successfully executed corporate strategies, collectively generating a threefold increase in revenue during his tenure. Previously, Strong served as President of the Teleflex Interventional franchise and was responsible for expanding the company's penetration in the interventional cardiology and radiology spaces. Additionally, Mr. Strong held executive leadership roles at Vidacare Inc. (acquired by Teleflex in 2013) and at AtriCure, Inc. He has also served on the Board of Directors of Vivasure Medical and Obvius Robotics. "I am honored to assume this position and am excited to get started. Q'Apel is a leader in the neurovascular space, recognized for driving innovation and its customer-centricity," commented Strong. "I look forward to working with the Board of Directors, the executive leadership, and the global Q'Apel team to drive growth, shape our future, and to realize our full potential." About Q'Apel Medical: Q'Apel Medical is revolutionizing neurovascular interventions. Inspired by the evolving needs of our customers, our novel approach allows us to solve clinical challenges where others fall short. We are up for the task, the more complex the better. Our team thrives on creating high quality uniquely engineered products, designed in partnership with neurovascular specialists, that address what is needed right now, yet with the versatility to focus on what is coming next. For more information, visit Media Contact:Charlene HerndonSPRIG Consultingcharlene@ View original content to download multimedia: SOURCE Q'Apel Medical Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
21 minutes ago
- Yahoo
Woman Reveals How a Lip Flip Impacted Her Sex Life as She Details Procedure's Shocking Side Effects (Exclusive)
In May, aesthetic nurse injector Brooke Carrero posted a TikTok video detailing the side effects of a lip flip, which involves injecting neurotoxin to the area above the upper lip for a plumper, fuller effect Carrero used her video as a PSA to patients interested in the enhancement, which she said affected how she drank water and pronounced certain words Speaking with PEOPLE exclusively, Carrero reveals how the effects, which lasted around 48 hours, also impacted her sex life: "My skill set probably went from a 10 down to a six"Brooke Carrero, a registered nurse trained in aesthetic injections, is getting loose lipped about one of the most common cosmetic procedures. She posted a viral TikTok video in May revealing some of the side effects caused by the cosmetic enhancement, which involves injecting neurotoxin, a substance used by injection brands like Botox, to relax the surrounding areas of the upper lip to make them flip upward, giving them a fuller appearance. Right now, Botox is not FDA-approved to treat the lips, unlike fillers, which is why it is considered "off-label" for lip flips as opposed to its relation to treating crow's feet and frown and forehead lines. Though, that doesn't mean lip flips are entirely off the market, causing curiosity around the procedure to grow; a report published by the National Library of Medicine discovered a 33% monthly increase in the search volume for lip flips from 2014-2024. Carrero, who is based in Philadelphia and practices under Becker Plastic Surgery and Dr. Kirk Lozada, shocked viewers when she revealed how the treatment made it more difficult to do ordinary activities, such as drinking out of a straw, brushing her teeth, applying lip gloss and even pronouncing words with Bs and Ps. But the most surprising admission from Carrero, 34, was how it impacted her sex life, a topic she was cheeky about in her TikTok video ("You can't blow out a candle, which means you can't blow anything. Use your imagination there," she joked), but open about in her interview with PEOPLE. "My skill set probably went from a 10 down to a six," she says. But, "I feel like I've gotten used to the way that my mouth kind of moves," she says, adding that her husband is so used to her experimenting with different treatments that he "laughs at me with my side effects." Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories. Luckily, Carrero notes that side effects usually last one to two days, while the lip flip itself can last up to three to four weeks. A playing factor is the number of units of neurotoxin injected into the patient. For her clients, Carrero commonly uses around four to six units (each of which costs around $14 at Carrero's practice), which the American Board of Facial Cosmetic Surgery also suggests. Yet currently, Carrero has 16 units injected around her mouth — and yes, she did them herself. "I am somebody that needs to try everything and expose myself to complications so I'm able to relate to my patients," she tells PEOPLE on why she goes to extremes for research purposes. is now available in the Apple App Store! Download it now for the most binge-worthy celeb content, exclusive video clips, astrology updates and more! After her video went viral, Carrero received tons of comments from people thanking her for cluing them in on the temporary hinderances of a lip flip. "No one tells you this!" one person wrote, while another person agreed, sharing that they wish they knew this before getting the treatment. At the end of the day, Carrero approaches the conversation around cosmetic treatments with an open mind. "There's nothing that you need to have done, like nobody needs a lip flip and nobody needs cosmetic procedures, but it's a matter of want. If it makes you feel good, don't let anyone make you feel otherwise." Read the original article on People


Medscape
25 minutes ago
- Medscape
Gastric Procedure Alleviates GERD Symptoms in Obesity
TOPLINE: In patients with obesity, endoscopic gastric remodeling (EGR) — a minimally invasive procedure — is safe and effective in relieving both typical and atypical gastroesophageal reflux disease (GERD) symptoms at 12 months post-procedure, while also reducing proton pump inhibitor (PPI) use. METHODOLOGY: EGR is a minimally invasive alternative to bariatric surgery that reduces gastric volume by approximately 70%, though its effect on GERD symptoms remains unclear. Researchers conducted a prospective cohort study at a tertiary referral bariatric center to examine EGR's effect on GERD symptoms in patients with at least one obesity-related comorbidity. Patients completed GERD and health-related assessments before and 12 months after the procedure. TAKEAWAY: Researchers included 50 patients (mean age, 41 years; mean BMI at baseline, 38.4; 95.8% women; 44% with GERD) who underwent EGR using either endoscopic suturing (16%) or plication (84%). All patients successfully underwent EGR without any serious adverse events. Between baseline and 12 months post-procedure, the mean Reflux Symptom Index score decreased from 5.1 to 3.8 (P = .007) and PPI use from 38% to 20% (P = .047). The presence of a hiatal hernia predicted a greater alleviation of GERD symptoms. IN PRACTICE: 'EGR may be considered a preferred option to co-manage both obesity and GERD, particularly in the lower obesity class,' the authors wrote. SOURCE: This study was led by Pichamol Jirapinyo, MD, MPH, Brigham and Women's Hospital, Boston, and published online in Clinical and Translational Gastroenterology. LIMITATIONS: This study did not include esophageal pH monitoring before or after EGR. Most participants were non-Hispanic women, which may have limited generalizability. Factors such as dietary modifications and medication use were not assessed. DISCLOSURES: The study received no external funding. Several authors reported being consultants; receiving research support, grants, or royalties; and having other ties with pharmaceutical companies. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.